Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK

INTRODUCTION: The results of recently completed cardiovascular outcomes trials in patients with type 2 diabetes mellitus (T2DM) suggest that sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide (GLP) 1 receptor agonists have enhanced cardioprotective properties in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lautsch, Dominik, Wang, Tongtong, Yang, Lingfeng, Rajpathak, Swapnil N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848348/
https://www.ncbi.nlm.nih.gov/pubmed/31583647
http://dx.doi.org/10.1007/s13300-019-00698-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848348/
https://www.ncbi.nlm.nih.gov/pubmed/31583647
http://dx.doi.org/10.1007/s13300-019-00698-9

Ejemplares similares